✦ LIBER ✦

Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

✍ Scribed by F. Maloisel; P. Dufour; J. P. Bergerat; R. Herbrecht; B. Duclos; A. Boilletot; C. Giron; P. Haennel; F. Oberling; D. Jaeck; G. Jung

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 400 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900215)65:4<851::aid-cncr2820650403>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy for breast carc

Combination chemotherapy for breast carcinoma using a combination of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) causes a platelet aggregation defect

✍ Anand Kumar; Pankaj Chaturvedi; Yogendra N. Gupta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 336 KB 👁 1 views

Cyclophosphamide, doxorubicin, and cispl

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

✍ Arnon I. Dreyfuss; John R. Clark; Barbara G. Fallon; Marshall R. Posner; Charles 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

Thirteen patients with carcinomas of major and minor salivary gland origin (nine adenoid cystic carcinomas and four adenocarcinomas) were treated with cyclophosphamide (500 mg/m2), doxorubicin (50 mg/m2), and cisplatin (50 mg/m2) (CAP) by intravenous injections on the first day of a 28-day regimen.

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w

Adjuvant doxorubicin and cyclophosphamid

Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma : Results of a randomized controlled trial

✍ Soo-Mee Bang; Dae Seog Heo; Ki Hyeong Lee; Jae Ho Byun; Heung Moon Chang; Dong-Y 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Low-dose mitomycin and weekly low-dose d

Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil

✍ Mariantonietta Colozza; Maurizio Tonato; Fausto Grignani; Stephen Davis 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views

Paclitaxel, 5-fluorouracil, and cisplati

Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma

✍ Yeul H. Kim; Sang W. Shin; Byung S. Kim; Jin H. Kim; Jong G. Kim; Young J. Mok; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Background: Although the clinical efficacy of paclitaxel in the treatment of gastric carcinoma has not been clearly defined, recent reports have suggested a possible role in the treatment of upper gastrointestinal carcinomas in vitro and in vivo. in this study, the authors evaluated the efficacy